June 3, 2020 Financial World Website News At 09:43 today, China New Pharmaceutical showed abnormal movement, with an additional sharp increase of 3.56%, setting a record high ( pre-requalified price). As of press time, the stock was 16.57 yuan per share, with a trading volume of 409.87 million lots, a turnover rate of 0.72%, an amplitude of 3.5%, and a volume ratio of 7.17.
Yesterday (2020-06-02), the net outflow of the stock was 4.9641 million yuan, the main force was 688,600 yuan, the net outflow of the mid-select was 4.6598 million yuan, and the net inflow of retail investors was 384,200 yuan.
In the past month, Zhongxin Pharmaceutical has been on the Dragon Tiger List for a total of 30 times, indicating that Zhongxin Pharmaceutical is not active.
Company is mainly engaged in the production and sales of traditional Chinese medicine, chemical drugs, and bioengineering drugs. As of March 31, 2020, China New Pharmaceutical 's operating income was 1.65596 billion yuan, and the net profit attributable to the parent company's shareholders was 16989 million yuan, a decrease of 10.5876% year-on-year, and basic earnings per share was 0.221 yuan.
Risk warning: The individual stock diagnostic results are produced by processing objective data through operational models. They are for reference only and do not constitute absolute investment advice.
